Jones Nauseef, M.D., Ph.D., is an Assistant Professor of Medicine within the Division of Hematology and Medical Oncology at Weill Cornell Medicine, and Assistant Attending physician at NewYork-Presbyterian Hospital. His clinical emphasis is on Genitourinary (GU) cancers and Phase I clinical trials. His research is focused on genomics of advanced prostate cancers, including neuroendocrine prostate cancer, as well as health care disparities.

Dr. Nauseef received his B.A. in Biology in 2006 from Swarthmore College, where he also participated in NCAA Track and Cross Country. In 2015, Dr. Nauseef earned his M.D. and Ph.D. in Molecular Physiology and Biophysics (Laboratory of Dr. Michael D. Henry) as part of the NIH-sponsored MedicalScientist Training Program (MSTP) at the Carver College of Medicine of theUniversity of Iowa. He continued his medical training at Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP), where he completed his Internship and Residency in Internal Medicine in 2018. He was honored to be the recipient of the David B. Skinner award at the conclusion of his residency. He remained at WCM/NYP for his Fellowship in Hematology and Medical Oncology, during which time he was awarded a 2020 Conquer Cancer Foundation of ASCO Young Investigator Award (YIA) and the 2021 Scott Wadler Fellows Clinical Research Award. During his Fellowship, Dr. Nauseef expanded his research focus to include the genomics of advanced prostate cancers and health care disparities in American men of African descent. He serves as co-investigator or collaborator on extramural grants for the latter project. Dr. Nauseef will continue these investigations as a member of the Englander Institute for Precision Medicine and inaffiliation with the New York Genome Center, with the primary goal of leveraging discoveries to develop clinical trials as part of the Phase I/Earlytherapeutics group at Weill Cornell's Meyer Cancer Center.